aflibercept vs brimonidine ophthalmic
Side-by-side comparison of aflibercept and brimonidine ophthalmic Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Eylea
Alphagan P
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Alphagan P eye drops help lower pressure in the eye. It is used for people with open-angle glaucoma or ocular hypertension.
AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
Alphagan P eye drops are used to lower high pressure inside your eye. This medicine is for people who have open-angle glaucoma or ocular hypertension. Glaucoma can damage the optic nerve and cause vision loss. Ocular hypertension means you have high pressure in the eye, which can lead to glaucoma.
AHZANTIVE is a VEGF inhibitor. VEGF is a protein that promotes the growth of new blood vessels. By blocking VEGF, AHZANTIVE helps to reduce the growth of abnormal blood vessels in the eye and decrease leakage.
Alphagan P is an alpha-2 adrenergic agonist. It works by decreasing the amount of fluid your eye makes. It also helps increase the amount of fluid that drains from your eye, which lowers eye pressure.
- • Bleeding in the eye
- • Eye pain
- • Clouding of the lens of the eye (cataract)
- • Separation of the vitreous gel from the retina
- • Spots in your vision
- • Allergic conjunctivitis (eye allergy)
- • Eye redness
- • Eye itching
- • Burning sensation in the eye
- • Small bumps on the conjunctiva (conjunctival folliculosis)
- Death 7,853
- Trouble seeing 2,013
- Using the medicine for something it's not approved for 1,509
- Loss of sight 1,459
- Eye infection 1,372
No adverse event reports.
Injections with AHZANTIVE may cause serious eye infections (endophthalmitis), separation of the retina (retinal detachment), and inflammation of blood vessels in the retina. Tell your doctor right away if you have any signs of these problems. AHZANTIVE may also increase the risk of blood clots that can cause stroke or heart attack.
Alphagan P may worsen problems caused by poor blood flow. Use caution if you have depression, problems with blood flow to your brain or heart, Raynaud’s phenomenon, low blood pressure when standing up, or thromboangiitis obliterans. Do not touch the tip of the container to your eye or any other surface. This can cause the solution to become contaminated and lead to serious eye damage and vision loss.
It is not known if AHZANTIVE can harm an unborn baby. AHZANTIVE should be used during pregnancy only if the benefit justifies the risk. It is also not known if AHZANTIVE passes into breast milk.
It is not known if Alphagan P will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. It is not known if Alphagan P passes into breast milk. Talk to your doctor before breastfeeding.
Also Compare — Nearby Drugs
Compare aflibercept with
How to Read This aflibercept vs brimonidine ophthalmic Comparison
aflibercept is classified in the Anti-VEGF (Ophthalmic Injection) drug class, while brimonidine ophthalmic sits within the Alpha-2 Agonist (Ophthalmic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aflibercept has 14,206 submissions while brimonidine ophthalmic has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aflibercept and brimonidine ophthalmic — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.